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Background/Aim. Malnutrition, a common problem in liver cirrhosis and HCC, may readily deteriorate the clinical functions
with resultant poor prognosis. Beside the hyper catabolic state frequently encountered in chronic liver disease and HCC, anorexia
and reduced food intake also worsen the malnutrition. The recently discovered peptide hormone ghrelin acts as a counterpart
of leptin in regulation of food intake and fat utilization. The aim of the present study was to investigate the ghrelin and leptin
levels in cirrhosis and HCC due to hepatitis B and D viruses, and the association of ghrelin and leptin with TNF-α,I L - 6a n d
the severity of the disease. Materials and methods. We measured serum ghrelin, leptin, TNF-α, and IL-6 levels using speciﬁc im-
munoassay in 45 patients (23 cirrhosis, 22 HCC) with HBV and/or HDV and in 25 control subjects. Results.I nc o m p a r i s o nt o
controls, serum ghrelin, TNF-α, and IL-6 levels were signiﬁcantly higher in cirrhosis and HCC (P<. 05), whereas serum leptin
levels were found decreased (P<. 05). There was a positive correlation between ghrelin and TNF-α, and a negative correlation
between leptin and TNF-α (P<. 05). Conclusion. In cirrhosis and HCC due to HBV or HDV, serum ghrelin levels were increased
with a corresponding decrease in serum leptin concentrations, acting as a physiological counterpart of ghrelin. The increasing
of ghrelin is more prominent in Child C cirrhosis and the level was correlated with TNF-α. The presence of nutritional and
metabolic abnormalities, including malnutrition, in cirrhosis and HCC may, at least partly, elucidate high ghrelin and low leptin
levels.
Copyright © 2006 Huseyin Ataseven et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
INTRODUCTION
Viralhepatitisistheleadingcauseoflivercirrhosisandhepa-
tocellular carcinoma (HCC) [1]. HCC is the ﬁfth most com-
mon cancer and the third leading cause of cancer-related
mortalityworldwide[2].Malnutritionisacommonproblem
in liver cirrhosis and HCC. This may cause deterioration of
clinical functions with resultant poor prognosis [3–7]. Liver
failure causesboth decreased protein synthesis and enhanced
protein breakdown, which together with anorexia and re-
duced food intake can lead to severe protein energy malnu-
trition and limit the capacity for regeneration and functional
recovery of the liver [8].
Ghrelin is a novel endogenous ligand for the growth hor-
mone (GH) secretagogue receptor that has recently been iso-
latedfrombothhumanandratstomach[9].Ghrelincontrols
energy balance, enhancing fat mass deposition and food in-
take through the activation of the hypothalamic nuclei and
the promotion of neuropeptide Y (NPY) and agouti-related
protein (AGRP) expression [10, 11]. Ghrelin administration
stimulates GH secretion independent of hypothalamic GH-
releasing hormone, and also causes weight gain and adipos-
ity by increasing food intake and reducing fat utilization in
rodents [12, 13]. Leptin is a peptide hormone and is pre-
dominantly produced by adipocytes [14]. Leptin is postu-
lated to regulate energy balance by suppressing appetite and
increasing energy expenditure [15–17]. The mechanism of
action in the hypothalamic nuclei is antagonistic to ghrelin:
leptin inhibits NPY and AGRP [18]. Also leptin plays a role
in the modulation of immune response and inﬂammation.
The increase in leptin production that occurs during infec-
tion and inﬂammation strongly suggests that leptin is a part2 Mediators of Inﬂammation
of cytokine cascade [19, 20]. Recent attention has been fo-
cusedontheliverproﬁbrogenicroleofleptininanimalmod-
els [21].
The eﬀect of ghrelin-like leptin is not exclusively medi-
ated by direct hypothalamic receptor activation, but also by
modulating cytokines [22]. Tumor necroses factor α (TNF-
α) and interleukin-6 (IL-6) are pleiotropic cytokines with
numerous immunologic and metabolic actions [23, 24]. The
TNF-α system activity is increased in liver cirrhosis and gen-
erally thought to be associated with several known cirrhosis-
related complications such as hyperdynamic circulation, sus-
ceptibility to infection, and hepatic encephalopathy [25, 26].
IL-6 is generally considered to be an important cytokine
in the network of cytokines that regulate immune reactions
andacutephaseresponses[27].AlinkbetweenIL-6andliver
ﬁbrosis/cirrhosis has also been reported [28]. Activation of
cytokinesystem,asobservedinseveralchronicinﬂammatory
conditions including liver cirrhosis, may result in increased
energy expenditure and reduced nutrition intake [29].
Patients with chronic liver diseases usually exhibit a lean
body as a result of hypermetabolism. They also suﬀer from
a diminished food intake and malnutrition status and lep-
tin is thought to be involved [30]. However there have been
very few reports on the association of ghrelin, leptin, and cy-
tokines in liver cirrhosis and HCC. Therefore in the present
study we evaluated the ghrelin and leptin levels in cirrhosis
and HCC due to hepatitis B and D viruses, and the associa-
tion of ghrelin and leptin with TNF-α,I L - 6 .
MATERIALS AND METHODS
Patients
Forty ﬁve patients (23 cirrhosis, 22 HCC) with HBs Ag (+)
and/or antidelta (+) were enrolled to the study. The diagno-
sis of cirrhosis was based on the typical ﬁndings of hepatic
cirrhotic appearance, splenomegaly, esophageal varices, and
ascites (by ultrasonography and upper gastrointestinal en-
doscope examinations, with supporting biochemical data or
histologically [31]). The diagnosis of HCC was made accord-
ing to Barcelona classiﬁcation [32]. Exclusion criteria were
included: (i) concomitant acute complications, such as gas-
trointestinal hemorrhage, hepatic, encephalopathy or clini-
cal signs of infection, (ii) renal insuﬃciency, (iii) the patient
was treated with drugs that alter carbohydrate metabolism,
or hypothalamic-pituitary axis.
Twenty ﬁve healthy individuals with normal medical his-
tory, physical examination, and blood chemistry served as
control group. The local ethics committee approved the
studyprotocol.Writteninformedconsentwasobtainedprior
to enrolment.
Laboratoryinvestigationandimmunoassays
All blood samples were drawn at 08 : 00–09 : 00 am after
an overnight fast. The aspartate aminotransferase, alanine
aminotransferase,serumalbumin,totalbilirubin,andalpha-
fetoprotein were measured at biochemistry department in
Table 1: Demographic and clinical characteristics of control and
patients groups.
Control Cirrhosis HCC
(n = 25) (n = 23) (n = 22)
Age (year) 37,12±7,57 45,54±7,99 59,82±8,77
Sex (F/M) 14/11 12/11 7/15
Etiology
Hepatitis B 13 13
Hepatitis B+D 10 9
Child-Pugh
Child A 5 3
Child B 8 8
Child C 10 11
Ascites 14/23 17/22
Tumor
Single/multiple — 13/9
Tumor Size (mm) — 37,29±25,63
routine clinical practice. Serum samples for ghrelin, leptin,
TNF-α,andIL-6werestoredat −20◦C.Ghrelin,leptin,TNF-
α, and IL-6 levels were analyzed with ELISA kits (TNF-α,I L -
6 kit was purchased from Bio-Source International Inc, 542,
Flynn Road, Camarillo, California, USA; Ghrelin kit from
Phoenix International, Inc, USA; and Leptin kit from DRG
International, Inc, USA).
Statisticalanalyses
All data were analyzed by SPSS software (Statistical Pack-
age for the Social Sciences), version 10.0 for Windows. Data
were presented as mean ± standard deviation unless noted
as diﬀerent. Comparisons between subjects groups were an-
alyzed using the nonparametric Mann-Whitney U test. The
relationship between ghrelin, leptin, TNF-α, IL-6, AFP, and
Child-Pugh score were determined by Spearman’s correla-
tion. P value of <. 05 was considered statistically signiﬁcant.
RESULTS
Demographic and clinical characteristics of control and pa-
tient groups are shown in Table 1. Mean age and gender be-
tween the control group and cirrhosis group were compara-
ble (P>. 05). Patients in the HCC group were older, and
more likely to be male than the cirrhotic patients and control
group (P<. 05). All the patients in cirrhosis and HCC group
were positive for hepatitis B surface antigen. Antidelta anti-
core was present in 43.5% of the cirrhotic group and 40.9%
of the HCC group. Presence of HDV between cirrhosis and
HCC groups was comparable (P>. 05).
AccordingtoChild-Pughstage,ﬁve(21.7%)ofthe23cir-
rhotic patients were Child A, eight (34.8%) were Child B, ten
(43.5%) were Child C; three (13.6%) of the HCC patients
were Child A, eight (36.4%) were Child B, eleven (50%) were
Child C.Huseyin Ataseven et al 3
Table 2: Biochemical characteristics of control and patients groups.
Control Cirrhosis HCC
(n = 25) (n = 23) (n = 22)
Ghrelin (ng/mL) 7.55±0.98 9.71±1.67∗ 8.13±0.77†
Leptin (ng/mL) 10.25±2.49 4.23±2.06∗ 4.18±1.68†
TNF-α (pg/mL) 3.33±1.21 10.38±3.88∗ 8.8±3.4†
IL-6 (pg/mL) 4.56±2.01 5 .65±5.19∗ 33.27±16.38††
AST (U/L) 20,62±6,09 103,16±47,13∗∗ 158,71±65,61†††
ALT (U/L) 19,25±4,58 81,16±47,62∗∗ 117,33±75,09†††
Bilirubin (mg/dL) 1,07±0,17 3,94±3,41∗ 3,01±2,61†
TProtein (gr/dL) 7,14±0,62 6,81±1,01 7,11±0,91
Albumine (gr/dL) 4,41 ± 0,35 2,75±0,76∗∗ 2,89±0,72†††
AFP (IU/mL) — — 3346 ±4953
∗P<. 05 control: cirrhosis group
∗∗P<. 001 control: cirrhosis group
†P<. 05 control: HCC group
††P<. 01 control: HCC group
†††P<. 01 control: HCC group.
Serum ghrelin, TNF-α, and IL-6 levels were signiﬁcantly
higher in cirrhosis and HCC groups compared to in the con-
trol group (P<. 05). On the other hand, serum leptin levels
were signiﬁcantly lower in cirrhosis and HCC groups com-
pared to in the control group (P<. 05). These diﬀerences
were not gender speciﬁc in the cirrhosis and HCC groups
(P>. 05). Serum ghrelin levels in Child C cirrhosis tended
to be higher than Child A cirrhosis (P<. 05). Serum levels
of ghrelin, leptin, TNF-α, IL-6, liver function tests, and alpha
feto protein (AFP) are shown in Table 2.
A signiﬁcant positive correlation was found between
ghrelin and TNF-α,( r :0 .290, P<. 05). There was a negative
correlation between ghrelin and leptin (r = 0.302, P<. 05).
However no correlation was found between ghrelin, leptin
and AST, ALT, AFP (P>. 05). Correlations of ghrelin with
leptin and TNF-α are shown in Figures 1 and 2.
DISCUSSION
HBV infection is still the most serious cause of chronic liver
diseaseinTurkey[33].Turkeyisoneofthecountrieswithin-
termediate endemicity in the European region of the World
Health Organization (WHO) [34]. A higher frequency of
dual HBV/HDV infection has been described in patients of
HCC and consequential severe necro-inﬂammation may be
an additional factor for the promotion of HCC [35].
The nutritional and metabolic consequences of cirrho-
sis have attracted considerable interest over the past decade
because malnutrition and hypermetabolism are commonly
found in cirrhotic patients [3]. In addition, malnutrition is
a well-established risk factor inﬂuencing survival in patients
with cirrhosis and can modify the prognosis [36].
Ghrelin and leptin are important regulators of appetite
and energy balance [22]. There are numerous studies about
the role of leptin in malnutrition of cirrhotic patients. But
little is known about malnutrition in HBV and HDV coin-
fected cirrhosis and HCC. This is the ﬁrst study concerning
this issue.
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Figure 1: The relation of ghrelin and leptin. There was a negative
correlation between ghrelin and leptin (r :0 .302, P<. 05).
In accordance with the previous report [37], we estab-
lished that serum ghrelin levels increased in cirrhosis and
HCCduetoHBVorHDVthancontrolgroup,whereasleptin
was found decreased in cirrhosis and HCC.
The recently discovered hormone, ghrelin, may well be
the bridge connecting with general metabolism. As ghrelin
anticipates the initiation of meals and releases GH, it has
been postulated that ghrelin integrates anabolic changes in
the body. In catabolic situations like in cirrhosis, raised ghre-
linlevelsmayinduceacombinationofenhancedfoodintake,
increased gastric emptying and food assimilation. These ac-
tions of ghrelin are the opposite of leptin which reduces food
intake and selectively eliminates fat mass. Thus, both pep-
tides may act as physiological regulators of energy balance in
an extensive range [38].4 Mediators of Inﬂammation
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Figure 2: The relation of ghrelin and TNF-α.T h e r ew a sap o s i t i v e
correlation between ghrelin and TNF-α (r :0 .290, P<. 05).
Several studies have shown that circulating leptin lev-
els are modestly elevated in patients with alcoholic cirrhosis
[39, 40]. While some studies have supported these ﬁndings,
others have reported low serum leptin levels in posthepatitis
cirrhotic patients [30, 41–45]. In addition, nutritional status
of cirrhotic cases represents a wide range, from normal to se-
vere malnutrition, connected with the severity of the disease
[7, 41]. It is well known that insulin resistance is present in
cirrhosis due to HCV or alcohol [46, 47]. Insulin resistance,
therefore, might well explain elevated leptin levels in these
patients. Leptin is predominantly produced by adipocytes.
Greco A V et al [44] demonstrated that the decrease in cir-
culating levels of leptin strongly reﬂects the degree of malnu-
trition and fat mass in posthepatitis cirrhosis. Insulin resis-
tance is less common in cirrhosis due to HBV or HDV than
alcohol or HCV. Hypoleptinemia, thus, could well be a con-
sequence of malnutrition and fat mass reduction in HBV or
HDV cirrhosis rather than the insulin resistance.
Serum ghrelin levels were signiﬁcantly elevated in Child
C cirrhosis compared to Child A grade (P<. 05). Since the
likelihood of metabolic decompensation and clinical com-
plications increases with Child’s classiﬁcation [48], ghrelin
could potentially counteract these challenges in Child C cir-
rhosis by its various metabolic functions like the modulation
of energy balance, stimulation of appetite, and food intake.
In keeping with a recent study [37], we found serum
ghrelin levels signiﬁcantly elevated in HCC due to HBV or
HDVthanin thecontrolgroup.Meanwhileserumleptin lev-
elsinHCCweresigniﬁcantlylowerthaninthecontrolgroup.
Serum ghrelin and leptin concentrations, however, did not
diﬀer between cirrhosis and HCC. Since HCC patients pre-
dominantly composed with cirrhotic patients in the present
study, the change in ghrelin and leptin may be relevant to
themetabolicdisturbancesduetocirrhosisratherthanHCC.
Tacke et al reported a correlation with AFP and serum ghre-
lin levels. Nevertheless, our results did not corroborate this
ﬁnding.
We found that serum TNF-α signiﬁcantly increased in
cirrhosis and HCC (P<. 05, for both). Similarly, serum IL-6
was increased in both groups but the change was more dis-
tinctive in HCC group (P<. 001). Increased endogenous
TNF-α in advanced liver disease is generally believed to be a
consequence of chronic liver failure, which is associated with
endotoxin-dependent macrophage stimulation and with a
decrease in cytokine clearance [49]. Similarly, a link between
IL-6 and liver ﬁbrosis/cirrhosis has also been reported [28].
TNF-α a n dI L - 6a p p e a rt ob ei m p o r t a n tc a c h e c t i cp r o c e s s
mediators; although this association is not completely estab-
lished [50, 51]. Also Toda et al [52] reported that IL-6 has a
direct mitogenic eﬀect on hepatic stellate cells. The presence
of more prominent raise of IL-6 in HCC may be linked to
mitogenic aﬀect of IL-6.
In the present study, TNF-α correlated positively with
ghrelin and negatively with leptin. The relation of ghrelin
with TNF-α raises the possibility of the direct eﬀect of TNF-
α upon ghrelin or the impact of disease severity upon both
ghrelinandTNF-α. The eﬀect of leptin is not exclusively me-
diated by direct hypothalamic receptor activation but also by
modulating cytokines such as TNF-α [19, 20]. In the present
study, contrary to previous reports, the presence of nega-
tive correlation between TNF-α and leptin suggests that the
eﬀect of disease severity upon leptin is a more imperative
factor than TNF-α in cirrhosis and HCC due to HBV or
HDV.
In conclusion, ghrelin level is elevated whilst leptin is de-
c r e a s e di nc i r r h o s i sa n dH C Cd u et oH B Va n dH D V .I n -
creased ghrelin levels as counterpart of decreased leptin, at
least, represents malnutrition in these patients. Additionally,
the relation of ghrelin with cytokines and Child-Pugh stage
may be explained by the possible aﬀect of disease severity
upon ghrelin.
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